Tag: Abiomed
SCAI 2020: PROTECT III shows placing Impella prior to high-risk PCI associated with lower mortality
Data from more than 1...
ADVERTORIAL: Further data underline the critical role of Impella Heart Pumps in Protected PCI
Findings from an inte...
New trial to evaluate role of Impella in preventing heart failure in STEMI patients
A pivotal, multicentr...
FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps
Abiomed has announced...
AHA 2018: Pilot study paves way for future evaluation of delaying reperfusion in STEMI patients
A pilot study compari...
Abiomed receives FDA approval for Impella CP with SmartAssist and Optical Sensor
Abiomed has received ...
FDA grants Abiomed pre-market approval for is Impella RP for right heart failure
Abiomed has received ...
Study indicates that Impella heart pump reduces acute kidney injury during high-risk PCI
A new study published...
FDA pre-market approval for the Impella heart pump for high-risk PCI now includes Impella CP
Abiomed has expanded ...
